Cystic Fibrosis in Adults Flashcards

(42 cards)

1
Q

How common is cystic fibrosis?

A
  • Most common autosomal recessive disorder in caucasians
  • 1 in 2000/2500 caucasian live births
  • 1 in 25 carriage rate
  • Respiratory failure is the cause of death in 90% of people with CF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why has the survival for CF improved?

A
  • CF centres
  • MDT teams
  • Physio
  • Nutrition/enzymes
  • Antibiotics
  • Aggressive approaches
  • Annual flu/pneumococcal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the Cystic Fibrosis protein?

A

Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and chloride channel in vertebrates that is encoded by the CFTR gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What occurs due to the mutation of the CFTR gene?

A

Abnormal transport of chloride and sodium across epithelium

  • Reduced chloride secretion from epithelium
  • Reduced Na absorption from lumen

= thick secretions
= Impaired bacterial killing via neutrophils as normal chloride required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the advantage in mice being heterozygous for the CFTR gene?

A

Increased resistance to salmonella, cholera toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 5 classes of disease: pancreatic insufficiency?

A

Class 1: no synthesis G542X

Class 2: Increased degradation DF508

Class 3: Defective reg G551Db

Class 4: Abnormal conduction R117H

Class 5: Reduced synthesis/trafficking A455E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are challenges for patients in CF for adults?

A
  • Transition is a major challenge, new MDT team
  • Prognosis
  • Promise of new drugs
  • Possibility of lung transplant
  • Other conditions: diabetes, liver disease, osteoporosis, fertility issues, haemoptysis etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are commonest presentations of CF in newborns?

A
  • Meconium Ileus (15%)
  • Prolonged conj jaundice
  • Newborn screening
  • Screening due to FH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are commonest presentations of CF in infancy and children?

A
  • FTT (29%)
  • Abnormal stools (24%)
  • Recurrent LRTI/symptoms (40%)
  • Rectal prolapse 20%
  • Nasal polyps (10-40%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are commonest presentations of CF in adults?

A
  • Infertility (esp in men)
  • Bronchiectasis
  • Clubbing
  • Mild resp symptoms/recurrent LRTI (40%)
  • Hyperinflation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why does pulmonary infection occur in CF?

A

CFTR abnormality

  • Decreased mucociliary clearance
  • Increased bacterial adherence
  • Decreased endocytosis of bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Features of progressive airflow obstruction

A
  • Survival related to FEV1
  • Increasing exertional dyspnoea
  • Brochodilators (inhaled nebulised)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Features of respiratory failure

A

Type 1 = decreased PaO2

Type 2 = Decreased PaO2, Increased PaCO2

Oxygen, ambulatory oxygen
Nocturnal NIV, symptomtic relief, bridge to LTx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does a cystic fibrosus CT scan usually show?

A
  • Tramlines
  • Signet rings
  • Mucous plugging
  • Consolidation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Features of Type 2 Diabetes Mellitus in CF

A
  • Often preceded for years by falling lung function, BMI
  • Almost never get DKA, type 1 DM only rarely seen
  • Complication risk same as non CF pts but pulmonary disease gets there first
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CF issues in type 2 diabetes mellitus

A
  • Compliance with diet a problem
  • Low sugar/high fibre diet not appropriate
  • OGTT/HBA1C used but not perfect
  • Insulin of benefit, not so much oral hypoglycaemics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Features of Osteoporosis in CF

A
  • Significant BMD (bone mineral density) decrease in 1/3 adults patients with CF
  • Slower gain, faster loss, worse the sicker you are
  • May exclude lung transplant
18
Q

What does osteoporosis in CF occur due to?

A
  • Malnutrition and low BMI
  • Steroids
  • Delayed puberty and hypogonadism
  • Inflam cytokines from sepsis (we know BMD falls in septic pts)
  • Vitamin D/K deficiency
  • Lung Tx/drugs
19
Q

What are predictors of low BMD (bone mineral density)?

A
  • Low FEV1
  • Frequent a/b courses
  • Steroids
  • Low BMI
  • Low exercise
  • Age
  • Male
  • Diabetes
  • Vit D
  • Delayed puberty
20
Q

Features of Pneumothorax in CF

A
  • 3-4% Cf patients during lifetime
  • Especially if older, more severe obstructive lung disease
  • 16-20% > 18
  • Males=Females

Treatment same as other patients = drain, pleurodesis, surgery

21
Q

Features of Haemoptysis in CF

A
  • Bronchial wall destruction
  • Minor (60%) = blood streaking common, no special treatment
  • Massive in 1% patients each year, may need embolisation
22
Q

Risk factors of Haemoptysis

A
  • Severity
  • Exacerbations
  • Fungal
  • Liver disease
  • Vitamin K deficiency
23
Q

Microbiology: features of Pseudomonas Aeroginosa

A
  • Colonisation increases with age
  • Acquired from enviroment, other CF patients, segregation and disinfection policies

Colonisation associated with: reduced life expectancy, rapid decline in lung function

First isolation: attempt eradication - 3 months of treatment

24
Q

Microbiology: features of Burkholderia Cepacia

A
  • Environmental organism (causes onion rot)
  • Acquired from: environment, other CF patients (epidemic strains more virulent), segregation policies
  • Colonisation associated with: reduced life expectancy 16 vs 39 years, rapid decline in lung function, do worse in pregnancy
  • Innate resistance to most antibiotics
  • Genomovar III contraindication for transplantations
25
Features of Sternotrophonas Maltophilia
- Increasing frequent colonisation - Usually after pseudomonas, but can occur as first Gram negative infection - Multiple antibiotic resistance - Unsure if detrimental to prognosis
26
Features of Aspergillus
- Comes from environment, not person to person - Can cause spectrum disease - E.g. coloniser, infection, allergy
27
Features of Non TB Mycobacteria in CF (NTM)
Isolated in up to 13% CF patients - MAI = 75% of these - M. abcessus grows rapidly, comprises 16% of NTM patients with CF May not need treatment: - Treat if clinical/lung function/CXR deterioration
28
Features of Mycobacterium Abscessus
- Currently rapid increase in number of isolates - Highly resistant - Contraindication for transplantation - Eradication: 1 month in hospital then maintenance treatment for 1 year- side effects, failure
29
Treatment for pulmonary infection
- Treat early and aggressively with antibiotics - Oral antibiotics (e.g. Staph, Haemophilus, Pneumococcus) - IV antibiotics (e.g. PA, Stenotrophomonas, Burkholderia) - Two antibiotics, liaise with microbiology - If multiply resistant, test for synergy between antibiotics - Large doses (include volume distribution, increased clearance) - Two week courses - Indwelling suncutaneous ports (vascuports)
30
Is there evidence for antibiotics in acute exacerbations?
- Not much evidence for regular ivs but anecdotally seem to work in some patients - Concerns re-resistance
31
Antibiotics: Can resistance it vitro still work in combination in vivo?
Yes it may still work - CF organisms often grow poorly on standard media - Rise in FEV1 in iv tobra/ceftaz trial not related to whether ps was sensitive to a/b or not - Never use 1 iv: avoids resistance. Some evidence that 2 a/b use reduces readmiss rates - Synergy testing may help
32
Features of Nebulised or Inhaled antibiotics
- Not used instead of intravenous antibiotics - Colobreathe inhaler or ocassionally colomycin nebuliser - TOBI inhaler or occasionally Tobramycin nebuliser: it treats Pseudomonas aeruginosa
33
Why would bronchodilators be used in CF?
CF patients may have airway obstruction due to: - Asthma/Atopy: BHR in 40% CF patients - Mechanical: bronchial plugging, inflammation > bronchial wall thickening - Many patients (especially milder disease): increase in FEV1 despite absence typical asthma symptoms
34
Features of airway clearance: Chest Physio
- Autogenic drainage, active cycle of breathing, huffing - Airway oscillating devices (PEP device), percussion vests - All patients with sputum should do physio: compliance issues - Expensive devices not routinely recommended as lack of data
35
Features of Mucolytics
- Reduce viscosity of phlegm | - Making it easier to expectorate
36
Examples of Mucolytics
- Pulmozyme - Hypertonic saline - Carbocysteine - Bronchitol
37
What is the suggested regime to optimise drug delivery?
- Bronchodilator MDI - Hypertonic saline - Chest physio - DNAse - (Neb antibiotics)
38
Features of anti-inflammatory therapy: Azithromycin
- Antibacterial and anti-inflammatory effects - Reduces biofilms - Increased lung function, decreased decline, decreased exacerbation rate by 40%
39
What are new drugs - Potentiators and Correctors in CF?
- Ivacaftor - Ivacaftor/Lumacaftor (Orkambi) - Tezacaftor/Ivacaftor (Syndeco) - Triple therapies in development Small benefit in lung function. More significant benefit is fall in pulmonary exacerbations and weight gain
40
What are indications for a double lung transplant?
- Rapidly deteriorating lung function - FEV1 <30% predicted - Life threatening exacerbations - Estimated survival <2 years
41
Survival features for a double lung transplant
- 70-80% at 5 years - 50% at 10 years - Gradual attrition due to bronchiolitis obliterans - Viewed as a measure to prolong survival and improve quality of life
42
What are other things to consider to improve quality of life?
- Oxygen and NIV - Exercise - Support - Advanced care planning - DNAR